Experts warn global goal to cure or treat Alzheimer's by 2025 is at risk

According to a paper published in Alzheimer's Research & Therapy, prominent experts in the field of Alzheimer’s disease (AD) state that under current conditions, only a limited number of disease-modifying therapies have a chance to be approved and available to patients by 2025.

In "Drug Development in Alzheimer's Disease: The Path to 2025," the authors dissect the current realities and challenges of AD drug development and offer solutions to stimulate progress.

During the 2013 G8 Dementia Summit held in London, member nations established the goal to identify a disease-modifying therapy for dementia by 2025, setting the stage for coordinated global actions, including the initiation of the World Dementia Council. Many national policies or plans across the globe have also identified 2025 as the goal to effectively treat or prevent AD, including the US National Plan to Address Alzheimer's Disease.